Brooke Richer, NP
Adult Health · Woonsocket, RINPI 1194482828
Payments from drug & device makers
What this record shows
Almost everything reported here is food and beverage — 100.0% of the total across 11 separate payments, which is the pattern of a clinician who attends manufacturer presentations rather than one with a consulting arrangement. 9 manufacturers reported payments, led by Medtronic at 32.9% of the total. Reporting peaked in 2022 at $176 and has fallen 87.8% since, to $21 in 2025. That places this record below the midpoint for adult health clinicians in RI, where the typical reported total is $228.
Across 11 payments — averaging $26.74 each. Meals, travel, consulting and speaking fees, gifts and royalties reported by drug and device makers.
- Medtronic$97
- Novartis$45
- Shockwave Medical, Inc$38
- Boston Scientific$25
- Bayer$25
- ZOLL Services LLC (a/k/a ZOLL Lifecor Corp)$21
- plus $43 from 3 others
What the payments were for
- Food & beverage$294100%
Most of this is food and beverage — typically meals provided during product presentations at a clinic or hospital. Nationally that is the single largest category of reported payments by count.
General payments by program year
Who reported the general payments
Companies are grouped under their corporate parent — a single manufacturer often files under several CMS reporting entities. Research and ownership payments are counted separately and are not in this table.
| Company | Payments | Total |
|---|---|---|
| Medtronic | 1 | $97 |
| Novartis | 2 | $45 |
| Shockwave Medical, Inc | 2 | $38 |
| Boston Scientific | 1 | $25 |
| Bayer | 1 | $25 |
| ZOLL Services LLC (a/k/a ZOLL Lifecor Corp) | 1 | $21 |
| Terumo Medical Corporation | 1 | $21 |
| Merck | 1 | $19 |
| Cardiovascular Systems Inc. | 1 | $3 |
How this compares
$294 in reported general payments places this provider in the 50th percentile of 65 adult health providers in Rhode Island.
Medicare billing
What this is not: this is the amount Original Medicare Part B allowed for services this provider billed in 2024. It is not their income. It excludes Medicare Advantage — now more than half of all Medicare enrollment — along with Medicaid and all commercial insurance, and it is gross practice revenue before staff, rent, supplies and malpractice premiums. CMS also suppresses any figure covering ten or fewer patients, so low-volume providers appear smaller than they are.
Most prescribed under Part D
| Drug | Claims | Cost to plans & patients |
|---|---|---|
| EliquisApixaban | 13 | $9,503 |
| Metoprolol Succinate | 54 | $713 |
| Bisoprolol Fumarate | 13 | $398 |
| Atorvastatin Calcium | 31 | $343 |
| Lisinopril | 28 | $295 |
| Losartan Potassium | 18 | $239 |
| Amlodipine Besylate | 28 | $174 |
| Metoprolol Tartrate | 14 | $116 |
| Carvedilol | 13 | $102 |
| Furosemide | 17 | $74 |
Paid to pharmacies, not to this prescriber.
Other adult health in Woonsocket
- Karen WilmotWoonsocket$28
- Jacqueline AlbrikesJohnston$14K
- Elizabeth McGrathBarrington$7K
- Kathleen FranchinaWarwick$5K
- Deirdre CoutureCranston$5K
- Janine ZuromskiEast Greenwich$5K
- Christine UyProvidence$4K
- Kathleen RasslerEast Greenwich$3K
- Lindsay LeddyWarwick$3K
- Phina MayuProvidence$2K
Where these figures come from
- Payments: CMS Open Payments, program years 2019–2025 (publication P06302026_06032026).
- Billing: Medicare Physician & Other Practitioners, data year 2024. Original Medicare Part B only.
- Identity: NPPES NPI Registry, July 2026.